We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+2.36%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$26.2B
AUM Growth
+$914M
(+3.6%)
Cap. Flow
+$1.01B
Cap. Flow
% of AUM
3.87%
Top 10 Holdings %
Top 10 Hldgs %
32.55%
Holding
1,591
New
69
Increased
817
Reduced
431
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$107M |
| 2 |
EXL Service
EXLS
|
+$72M |
| 3 |
Apple
AAPL
|
+$64.3M |
| 4 |
Synopsys
SNPS
|
+$56.8M |
| 5 |
ServiceNow
NOW
|
+$54.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Halozyme
HALO
|
+$74.5M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$53.5M |
| 3 |
Edwards Lifesciences
EW
|
+$45M |
| 4 |
Abbott
ABT
|
+$40.3M |
| 5 |
Rockwell Automation
ROK
|
+$39.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.4% |
| 2 | Healthcare | 16.63% |
| 3 | Financials | 12.04% |
| 4 | Communication Services | 9.47% |
| 5 | Industrials | 8.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
St. Joe Company
JOE
$3.92B
| $740K | ﹤0.01% |
16,474
| – | – |
|
1127
ABM Industries
ABM
$2.82B
| $737K | ﹤0.01% |
14,409
+1,500
| +12% | +$81.6K |
|
1128
CorVel
CRVL
$3.17B
| $734K | ﹤0.01% |
6,600
+1,200
| +22% | +$134K |
|
1129
Werner Enterprises
WERN
$2.31B
| $734K | ﹤0.01% |
20,430
+1,600
| +8% | +$61.3K |
|
1130
Payoneer
PAYO
$2.42B
| $732K | ﹤0.01% |
72,900
| – | – |
|
|
GTM
1131
ZoomInfo Technologies
GTM
$1.11B
| $731K | ﹤0.01% |
69,600
+15,100
| +28% | +$161K |
|
1132
Community Bank
CBU
$3.45B
| $729K | ﹤0.01% |
11,816
+1,300
| +12% | +$83.2K |
|
1133
WSFS Financial
WSFS
$4.17B
| $728K | ﹤0.01% |
13,705
+1,400
| +11% | +$76.2K |
|
1134
IPG Photonics
IPGP
$3.62B
| $727K | ﹤0.01% |
10,000
+1,400
| +16% | +$108K |
|
1135
Cinemark Holdings
CNK
$4.35B
| $726K | ﹤0.01% |
23,432
+2,000
| +9% | +$61.9K |
|
1136
Core Scientific
CORZ
$6.49B
| $726K | ﹤0.01% |
+51,700
| New | +$764K |
|
1137
Enerpac Tool Group
EPAC
$1.89B
| $722K | ﹤0.01% |
17,574
+1,400
| +9% | +$64.1K |
|
1138
Global Net Lease
GNL
$1.9B
| $718K | ﹤0.01% |
98,346
+12,200
| +14% | +$93.7K |
|
1139
Nomad Foods
NOMD
$1.65B
| $718K | ﹤0.01% |
42,800
+2,100
| +5% | +$36.7K |
|
1140
Capri Holdings
CPRI
$1.79B
| $716K | ﹤0.01% |
34,000
-900
| -3% | -$24.5K |
|
1141
Extreme Networks
EXTR
$3.26B
| $715K | ﹤0.01% |
42,700
-100
| -0.2% | -$1.62K |
|
1142
Unifirst Corp
UNF
$5.23B
| $715K | ﹤0.01% |
4,179
| – | – |
|
1143
Walker & Dunlop
WD
$1.43B
| $715K | ﹤0.01% |
7,351
+900
| +14% | +$97.4K |
|
1144
Axcelis
ACLS
$4.47B
| $713K | ﹤0.01% |
10,200
-200
| -2% | -$16.6K |
|
|
AMED
1145
DELISTED
Amedisys
AMED
| $713K | ﹤0.01% |
7,851
+1,600
| +26% | +$147K |
|
|
ECHO
1146
EchoStar
ECHO
$26.6B
| $711K | ﹤0.01% |
31,042
-4,500
| -13% | -$109K |
|
1147
ManpowerGroup
MAN
$2.66B
| $710K | ﹤0.01% |
12,300
+1,900
| +18% | +$121K |
|
1148
NMI Holdings
NMIH
$3.38B
| $709K | ﹤0.01% |
19,300
+2,600
| +16% | +$101K |
|
1149
Insperity
NSP
$1.96B
| $709K | ﹤0.01% |
9,144
+1,200
| +15% | +$97.1K |
|
1150
FIVE9
FIVN
$2.34B
| $707K | ﹤0.01% |
17,395
+3,300
| +23% | +$119K |
|
Similar funds
VIA
Handelsbanken Fonder's Q4 2024 Portfolio in Review
As of Q4 2024, Handelsbanken Fonder held 1,591 positions worth $26.2B, up 3.6% from $25.3B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Handelsbanken Fonder deployed $1.01B of net new capital in Q4 2024, opening 69 new positions and adding to 817 existing holdings. Its largest new stake was GE Vernova: 105,537 shares worth $34.7M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 35% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Halozyme, an estimated $74.5M trimmed.
- Handelsbanken Fonder's largest Q4 2024 buy was GE Vernova: 105,537 shares worth $34.7M.
- Handelsbanken Fonder added most to Microsoft in Q4 2024, an estimated $107M increase.
- Handelsbanken Fonder's biggest Q4 2024 reduction was Halozyme, cutting an estimated $74.5M.
- Handelsbanken Fonder fully exited BeOne Medicines Ltd in Q4 2024, selling an estimated $5.92M.
- Handelsbanken Fonder's ten largest holdings make up 33% of its $26.2B portfolio in Q4 2024.
- Handelsbanken Fonder opened 69 new positions and closed 49 in Q4 2024.
- Handelsbanken Fonder's portfolio value rose 3.6% quarter-over-quarter to $26.2B.
Based on Handelsbanken Fonder's 13F filing for Q4 2024, filed 3 Feb 2025.